Product
Nanatinostat mesylate + Valganciclovir
1 clinical trial
1 indication
Indication
Advanced CancerClinical trial
A Phase 1 Study to Investigate the Mass Balance of [14C]-Nanatinostat and to Evaluate the Relative Bioavailability of Nanatinostat in Patients With Selected Advanced CancersStatus: Recruiting, Estimated PCD: 2025-02-01